← SynDRA
OSI-930
SynDRA canonical compound SYN0025686 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | KIT |
|---|
| Mechanism of action | VEGFR inhibitor |
|---|
All known targets
- KDR
- KIT
- FLT1
- CSF1R
- FLT4
- PDGFB
- PDGFRB
- RAF1
Mechanisms of action (all sources)
- KIT INHIBITOR
- VEGFR inhibitor
- Stem cell growth factor receptor inhibitor
- FLT1 INHIBITOR
- Vascular endothelial growth factor receptor inhibitor
- FLT4 INHIBITOR
- KDR INHIBITOR
- CSF1R INHIBITOR
- RAF1 INHIBITOR
- KDR MODULATOR
- KIT MODULATOR
Cross-references
Synonyms
- OSI 930
- OSI930
- OSI-930 is a multi-targeted tyrosine kinase inhibitor
- 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide
- G1PEG5Q9Y2
- RefChem:168670
- Tyrosine Kinase Inhibitor OSI-930
- C22H16F3N3O2S
- UNII-G1PEG5Q9Y2
- MFCD11100358
- MLS006010277
- SCHEMBL633719
- GTPL9383
- orb1305252
- OSI 930 [WHO-DD]
- SCHEMBL29352171
- CHEBI:91433
- GLXC-90038
- HMS3295O11
- HMS3654H03
- EX-A2118
- OSI 930?
- BDBM50356877
- EBC-11378
- NSC766887
- NSC800811
- s1220
- AKOS026750567
- CCG-264867
- CS-0174
- NSC-766887
- NSC-800811
- SB16588
- SDCCGSBI-0654359.P001
- NCGC00263159-01
- NCGC00263159-07
- NCGC00263159-08
- NCGC00263159-10
Look up OSI-930 in the interactive SynDRA portal →